Sarcopenia Treatment Market Report – 2025 Outlook, Trends, Share, Size & Forecast
MarkNtel Advisors has unveiled its latest research report on the Sarcopenia Treatment Market, providing an in-depth analysis of market dynamics, growth prospects, and competitive landscape. This report serves as a valuable resource for stakeholders aiming to capitalize on emerging opportunities and navigate potential challenges in the Sarcopenia Treatment industry.
Sarcopenia Treatment Market Size: 2025 Outlook
The Global Sarcopenia Treatment Market size was valued at around USD 3 billion in 2024 and is projected to reach USD 3.9 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 4% during the forecast period, i.e., 2025-30. The Global Sarcopenia Treatment Market is experiencing significant growth driven by numerous key factors. Extended awareness of sarcopenia, particularly among aging populations, is encouraging early analysis and intervention. As a result, both healthcare specialists and patients are more actively managing muscle loss related to aging. Upgrades in nutritional supplements, which include amino acids, vitamin D, and protein-based products, are playing a pivotal function in fighting sarcopenia. These nutritional supplements are being more prescribed as a part of a holistic method of treatment, enhancing muscles and energy. Furthermore, government projects and healthcare programs for assisting the elderly people, are boosting the marketplace growth.
U.S. tariffs are changing—are you prepared? Download your free sample PDF of the report for timely data and expert advice – https://www.marknteladvisors.com/query/request-sample/sarcopenia-treatment-market.html
? Scope of the Report
- Forecasts till 2030 with year-wise market breakdown
- Geographical and segment-level analysis
- Company profiles and strategic insights
- Key market drivers and restraints
- Analysis of market trends and investment opportunities
What’s Driving the Market?
Increasing Global Aging Population – The Global Sarcopenia Treatment Market is majorly driven by the growing global aging population. The number of people more than 65 years old globally is projected to increase by double, rising from 761 million in 2021 to at least 1.6 billion in 2050. Due to this demographic trade sarcopenia, a situation that affects a massive percentage of older adults, and other age-associated illnesses are becoming usual. People begin losing nearly 3 to 8 percent of their muscular mass every ten years after the age of 30. Throughout their lives, maximum males will lose roughly 30% of their muscular mass. Sarcopenia has been mentioned to influence up to 15% of people aged between 60 to 70 years and as much as 50% of people over 80 years of age. This lack of muscle is a serious difficulty for older populations because it can result in increased frailty, disability, and a high chance of falls and fractures.
What’s Holding Back Growth?
Limited Awareness & Lack of Standardized Diagnostic Criteria – The major challenge in the Global Sarcopenia Treatment Market is the very little knowledge of this problem along with the lack of standardized diagnostic criteria. Despite its occurrence among older adults, sarcopenia stays underrecognized and underdiagnosed in many parts of the world. Sarcopenia is a treatable condition that many older adults ignore as they believe that muscle weakness and lack of mobility are regular factors of getting older. The trouble is made even more difficult because of the lack of universal diagnostic guidelines. The diagnostic processes used which include imaging techniques, biochemical testing, and functional evaluations differ greatly among geographical locations and healthcare systems. The foundation for the National Institutes of Health and the European Working Group on Sarcopenia in Older People (EWGSOP) recommends guidelines for diagnosing sarcopenia in older adults. Instead, there is no global recognition of the proposed standardized techniques for diagnosing sarcopenia. This inconsistency results in hindering effective intervention by causing inconsistent treatment and delays in detection.
Access Full Market Insights & Key Statistics! https://www.marknteladvisors.com/research-library/sarcopenia-treatment-market.html
Use your official business email to connect with our team and enjoy full access with priority support.
Sarcopenia Treatment Market Segmentation
By Treatment Type
- Protein Supplements - Market Size & Forecast 2020-2030F, USD Million
- Vitamin B12 Supplements - Market Size & Forecast 2020-2030F, USD Million
- Vitamin D and Calcium Supplements - Market Size & Forecast 2020-2030F, USD Million
By Diagnostic Method
- Biochemical Tests - Market Size & Forecast 2020-2030F, USD Million
- Imaging Techniques - Market Size & Forecast 2020-2030F, USD Million
- Functional Assessments - Market Size & Forecast 2020-2030F, USD Million
- Others - Market Size & Forecast 2020-2030F, USD Million
By Distribution Channel
- Hospital Pharmacies Source - Market Size & Forecast 2020-2030F, USD Million
- Retail Pharmacies Source - Market Size & Forecast 2020-2030F, USD Million
- Online Pharmacies Source - Market Size & Forecast 2020-2030F, USD Million
- Other - Market Size & Forecast 2020-2030F, USD Million
By Region
- North America
- South America
- Europe
- The Middle East & Africa
- Asia-Pacific
? Industry Leaders: Who’s Dominating the Sarcopenia Treatment Market?
The market is highly competitive, with players launching innovation-driven products and investing in strategic partnerships. Key participants include:
- Pfizer Inc.
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Yeast Zydus Cadila, Ltd.
- Angel Yeast
- Makers Nutrition LLC
- Metabolic Technologies Inc.
- Metagenics LLC
- Haleon Group of Companies
- Abbott Laboratories
- Nestlé SA
- Eli Lilly
- Sanofi Inc.
- Novartis AG
- Amway Corporation
- Bayer AG
These companies are focused on health-based R&D, expansion, and functional ingredient diversification.
Looking for Global, Regional or country-specific reports on this market?
Visit our website or simply fill out the inquiry form, and our team will reach out with customized insights and support - https://www.marknteladvisors.com/query/request-customization/sarcopenia-treatment-market.html
? Frequently Asked Questions (FAQs)
- What are the main drivers of the Sarcopenia Treatment market?
- Which segment leads the Sarcopenia Treatment industry?
- What regulatory challenges impact product development?
- Who are the top players in the Sarcopenia Treatment industry?
About US:
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.
Contact Us:
MarkNtel Advisors LLP
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
For Sales Enquiries: sales@marknteladvisors.com
